In the long history of cardiovascular care at BWH, investigators in the Cardiovascular, Diabetes, and Metabolic Disorders Research Center have a track record of translating research findings into cardiovascular treatments, for example:
- Just over 10 years ago, BWH researchers found that ACE inhibitors dramatically improved survival in heart attack patients, making such treatment the international standard.
- In 2003, another BWH research team demonstrated that a new class of drugs called angiotensin receptor blockers is as effective as ACE inhibitors in preventing repeat heart attacks, providing yet another tool in the fight against heart disease.
- In 2005, BWH research in C-reactive protein revealed that measuring this marker of inflammation provides a more accurate indication of heart-disease risk than assessing cholesterol alone.
Our Departmental Affiliates
The Cardiovascular, Diabetes, and Metabolic Disorders Research Center engages the talent and resources of a diverse group of investigators spanning the departments of Surgery, Pathology, Radiology, Medicine, and Anesthesiology, Perioperative and Pain Medicine.
BWH investigators are nationally and internationally recognized for their contributions to advances in cardiovascular, diabetes, and metabolic disorders research as recipients of prestigious awards, including elected members of the American Society for Clinical Investigation, elected members of the National Academy of Sciences, Hermann Blumgart Award of the Society of Nuclear Medicine, and a Clinical Research Prize of the American Heart Association.. Additionally BWH investigators hold specialized grants to conduct interdisciplinary research, including program project grants.
To learn more about the hospital’s efforts in cardiovascular care, visit BWH’s Cardiovascular Center of Excellence site. For more information about the Cardiovascular, Diabetes, and Metabolic Disorders Research Center, email email@example.com.